Showing posts with label Found. Show all posts
Showing posts with label Found. Show all posts

Monday, 2 September 2013

Ruth Asawa Found Her Artistic Calling In An Internment Camp

Melissa Block talks to Paul Lanier, the son of artist Ruth Asawa, who died in her San Francisco home on Monday at the age of 87. She's known for many famous fountains in San Francisco and her intricate, abstract wire sculptures, which are in the collections of many major museums.

Copyright © 2013 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

MELISSA BLOCK, HOST:

Among the Japanese-American internees during World War II was Ruth Asawa. When she was 16, she and her family were sent to an internment camp at the racetrack at Santa Anita in California. They lived in the stables and Asawa recalled that the stench of horse manure hung heavily in the air. Later, the family was moved to a camp in Arkansas. But it was in this unpromising environment that Asawa found her calling. She spent her days drawing and painting. And after the war, she became a renowned artist.

If you've ever visited San Francisco, you've likely seen Asawa's work. She's known as the Fountain Lady because she designed so many of the city's fountains. And her intricate abstract sculptures, many of them crocheted from wire are now in the collections of many major museums.

Ruth Asawa died earlier this week in San Francisco. She was 87. Her son Paul Lanier joins me now to talk about his mother's legacy. And, Paul, thanks for being with us. We're so sorry for your family's loss.

PAUL LANIER: Thank you very much. And it's so incredible to be speaking to your audience about my mom.

BLOCK: Well, tell us a little bit about your mom's experience of internment. Did she talk much about it? What did she tell you?

LANIER: She said very little about it. And one of the things she mentioned is she met some Disney cartoonists who are also Japanese internees. And they taught her a lot about drawing. A lot of the internees made things out of wood and seashells and, of course, fabric and sewing. And she did a lot of drawing in camp.

BLOCK: Well after the war, your mother studied to become a teacher. And she was told that she would not get hired because she was Japanese-American.

LANIER: Yes. I guess her friends, and they were rightly so in advising her that no school could hire a Japanese right after the war. So she heard about Black Mountain College. And so she went and met all those incredible artists at that school.

BLOCK: And it was an incredible lineup at the time. Buckminster Fuller, the architect; Merce Cunningham, the choreographer and dancer; and the artist Josef Albers were all among her teachers, right?

LANIER: That's right. And Josef Albers, the father of modern color theory was her drawing teacher. And he was a very difficult teacher, very detailed, exacting drawing class.

BLOCK: How did your mother start sculpting with wire - these crocheted wire sculptures that she became so known for?

LANIER: She went to Mexico and saw that they were making these wire baskets to carry eggs. So she learned how to loop the wire. It's almost like crocheting. And so, she went back to Black Mountain and made one of these things. And Albers said, keep making those.

BLOCK: Well, we mentioned that your mother is so well known in the Bay Area for her public art, and especially the fountains all around San Francisco. Describe those fountains and the place that they have in public life there.

LANIER: There's her piece at Union Square at the Hyatt Hotel, the Bronze Fountain. She'd have classrooms full of school children helping her to shape the material to design that fountain.

BLOCK: How did they do that?

LANIER: Well, they worked with a material called baker's clay, which is a play dough. It's just flour, salt and water. And I think they made self portraits of themselves. And then so all these little figures are on part of the fountain. And many, many people, her friends and family, worked on that piece. She always tried to involve other artists and to help other artists and to have them help her on her commissions.

BLOCK: What's it like for you and your siblings to walk around San Francisco and see those fountains, see the stamp of your mother in so many places?

LANIER: It just seems normal because she was just our mom. And it's just part of normal growing up or our growing up.

BLOCK: Yeah. Well, Paul Lanier, thanks very much for talking with us about your mother. We appreciate it.

LANIER: Thank you very much.

BLOCK: That's Paul Lanier. His mother, the artist Ruth Asawa, died this week at the age of 87. Her memorial service will be held later this month in San Francisco's Golden Gate Park.

Copyright © 2013 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.


View the original article here

Friday, 19 July 2013

Gun found in Whitaker yard after shooting


By Michael DiVittorio

Published: Saturday, July 13, 2013, 1:01 a.m.
Updated 15 hours ago

Whitaker police have recovered a handgun believed to have been used in a shooting Thursday night when one person was wounded.

Police were called to Whitaker Way and Frank Street about 11:22 p.m. The victim was transported to a hospital. Allegheny County dispatch said homicide detectives were sent at 11:43.

Whitaker police Chief John Vargo said his department received a call Friday morning from a woman who saw a gun in her yard along Frank Street. Officers recovered a 22 mm revolver.

County police continue to investigate.

No further information about the victim or suspects was available.

Anyone with information regarding the shooting should contact county police at 412-473-3000.

Michael DiVittorio is a staff writer for Trib Total Media. He can be reached at 412-664-9161, ext. 1965, or mailto:mdivittorio@tribweb.com?subject=RE: Gun found in Whitaker yard after shooting story on TribLIVE.

Teachers playing gamesStation owner may determine new studio siteOfficials tour flood-damaged ElizabethMcKeesport natives kick off annual weekend reunionPower restored; weekend storms to be isolated‘Little Mermaid’ is a delight for kids — and their parentsYoung volunteers flood Mon-Yough with serviceWhitaker council hires part-time officerPittsburgh rally to address FirstEnergy plant deactivation plansWorld War II vet honored with Victory MedalKortz, Markosek criticize Pennsylvania budget effortsSubscribe today! Click here for our subscription offers.

View the original article here

Saturday, 6 July 2013

For Bioterror Threats, Currently Approved Drugs Found Effective In Laboratory Mice

Main Category: Infectious Diseases / Bacteria / Viruses
Also Included In: Tropical Diseases;  Bio-terrorism / Terrorism
Article Date: 11 Apr 2013 - 0:00 PDT Current ratings for:
For Bioterror Threats, Currently Approved Drugs Found Effective In Laboratory Mice
not yet ratednot yet rated
In the most extensive screen of its kind, Texas Biomed scientists in San Antonio have demonstrated the feasibility of repurposing already-approved drugs for use against highly pathogenic bacteria and viruses. The pathogens included emerging diseases and potential bioterror threats ranging from anthrax to the Marburg and Ebola viruses.

In testing a library of 1,012 Food and Drug Administration-approved drugs, commonly used for treatment of every-day ailments like diabetes and high blood pressure, the scientists found that ten were active against two or more bacteria and that 24 were active against two or more viruses.

Two drugs were found to be the most potent compounds in protecting mice against anthrax while one drug, chloroquine, once used to treat malaria, protected mice against Ebola virus, said Robert Davey, Ph.D., a Texas Biomed virologist.

The new study, which included authors Jean Patterson, Ph.D., and Ricardo Carrion, Ph.D., both of Texas Biomed, appears in the April 2013 issue of the journal PLOS ONE. Their findings came from a collaborative effort among Texas Biomed, independent research institute SRI International and the U.S. Army Medical Research Institute of Infectious Diseases. It was supported by funds from the Defense Threat Reduction Agency, the Defense Department's agency for countering weapons of mass destruction.

"Repurposing of existing drugs that may have unanticipated activities as potential countermeasures is one way to meet this important goal, since currently approved drugs already have well-established safety and pharmacokinetic profiles in patients, and manufacturing and distribution networks," the authors wrote. "Therefore, approved drugs could rapidly be made available for a new indication in an emergency."

The scientists found a variety of hits against two or more of these bio-threat pathogens, which were validated in secondary tests. As expected, antibiotic compounds were highly active against bacterial agents, but the researchers did not identify any non-antibiotic compounds with broad spectrum antibacterial activity.

Lomefloxacin and erythromycin were found to be the most potent compounds in protecting mice against anthrax. Lomeflaxacin is used to treat bronchitis and urinary tract infections. Erythromycin is used against respiratory tract infections.

The most noteworthy antiviral compound identified was chloroquine which disrupted virus entry and replication in cells of two or more viruses in vitro and protected mice against Ebolavirus.

Due to the demanding complexity of working with these agents under laboratory conditions as well as the fact that human drug clinical trials cannot be ethically conducted for any of these agents, conventional drug discovery and development approaches are particularly challenging. For these agents, the FDA must evaluate the efficacy of drugs on the basis of their activities in appropriate animal models, under agency guidance. Thus, drug-repurposing offers many advantages, particularly given the fact that human safety studies have already been conducted.

Members of the Texas Biomed team are presently pursuing whether the other drugs could be equally useful for treatment of these viruses.

"It would be important to determine if a combination of drugs could be more potent than each individual drug," Davey said. "Such synergy, when seen, usually means you can lower the dose of each drug and still have a big impact on the disease while minimizing bad side effects. Such work could prove useful as an easy frontline defense against these viruses."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Texas Biomedical Research Institute. "For Bioterror Threats, Currently Approved Drugs Found Effective In Laboratory Mice." Medical News Today. MediLexicon, Intl., 11 Apr. 2013. Web.
5 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'For Bioterror Threats, Currently Approved Drugs Found Effective In Laboratory Mice'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here